Investigation of the effect of ginger on the lipid levels: A double blind controlled clinical trial

Saudi Medical Journal

Volumn 29, Issue 9, 2008, Pages 1280-1284

  Alizadeh Navaei, Reza ^a   Roozbeh, Fatemeh ^a   Saravi, Mehrdad ^a   Pouramir, Mehdi ^a   Jalali, Farzad ^a   Moghadamnia, Ali A ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GINGER EXTRACT; LACTOSE; LIPID; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; ENZYMATIC ASSAY; FEMALE; GINGER; HUMAN; HYPERLIPIDEMIA; IRAN; LIPID BLOOD LEVEL; MALE; RANDOMIZED CONTROLLED TRIAL; RHIZOME; TRIACYLGLYCEROL BLOOD LEVEL;

CAPSULES; DOUBLE-BLIND METHOD; FEMALE; GINGER; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MALE; MIDDLE AGED;

EID: 58049125580     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bhandari U, Sharma JN, Zafar R. The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits. J Ethnopharmacol 1998; 61: 167-171.
2. Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent clacium channels. J Cardiovasc Pharmacol 2005; 45: 74-80.
3. Wei QY, Ma JP, Cai YJ, Yang L, Liu ZL. Cytotoxic and apoptotic activities of diarylheptanoids and gingerol-related compounds from the rhizome of Chinese ginger. J Ethmopharmacol 2005; 102: 177-484.
4. Grant KL, Lutz RB. Ginger. Am J Health Syst Pharm 2000; 57: 945-947.
5. Arfeen Z, Owen H, Plummer JL, Ilsley AH, Sorby-Adams RA, Doecke CJ. A double-blind randomized controlled trial of ginger for the prevention of postoperative nausea and vomiting. Anaesth Intensive Care 1995; 23: 449-452.
6. Hoffman T. Ginger: An ancient remedy and modern miracle drug. Hawaii Med J 2007; 66: 326-327.
7. Phillips S, Ruggier R, Hutchinson SE. Zingiber officinale (ginger)-an antiemetic for day case surgery. Anaesthesia 1993; 48: 715-717.
8. Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnacy: Randomized, double-masked, placebo-controlled trial. Obstet Gynecol 2001; 97: 577-582.
9. Jitoe A, Masuda T, Suprata DN, Gara IW, Nakatani N. Antioxidant activity of topical ginger extracts and analysis of contained curcuminoids. J Agri Food Chem 1992; 40: 1337-1340.
10. Krishnakantha TP, Lokesh BR. Scavenging of superoxide anions by spice principles. Indian J Biochem Biophys 1993; 30: 133-134.
11. Reddy AC, Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem 1992; 111: 117-124.
12. Cao ZF, Chen ZG, Guo P, Zhang SM, Lian LX, Luo L, et al. [Scavenging effects of ginger on superoxide anion and hydroxyl radical]. Zhongguo Zhong Yao Za Zhi 1993; 18: 750-751. Chinese.
13. Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005; 97: 227-230.
14. Ahmed RS, Sharma SB. Biochemical studies on combined effects of garlic (Allium sativum Linn) and ginger (Zingiber officinale Rosc) in albino rats. Indian J Exp Biol 1997; 35: 841-843.
15. Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of attherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr 2000; 130: 1124-1131.
16. Han LK, Gong XJ, Kawano S, Saito M, Kimura Y, Okuda H. [Antiobesity actions of Zingiber officinale Roscoe]. Yakugaku Zasshi 2005; 125: 213-217.
17. Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platel aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56: 379-384.
18. Veerkamp MJ, de Graaf J, den Heijer M, Blom HJ, Stalenhoef AF. Plasma homocysteine in subjects with familial combined hyperlipidemia. Atherosclerosis 2003; 166: 111-117.
19. Giral P, Bruckert E, Jacob N, Chapman MJ, Foglietti MJ, Turpin G. Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia. Atherosclerosis 2001; 154: 421-427.
20. Stazka J, Luchowski P, Urbanska EM. Homocysteine, a risk factor for atherosclerosis, biphasically changes the endothelial production of kynurenic acid. Eur J Pharmacol 2005; 517: 217-223.
21. Rasouli ML, Nasir K, Blumenthal RS, Park R, Aziz DC, Budoff MJ. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 2005; 181: 159-165.
22. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 2006; 96: 660-666.
23. Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 475-478.
24. Platel K, Srinivasan K. Influence of dietary spices and their active principles on pancreatic digestive enzymes in albino rats. Nahrung 2000; 44: 42-46.
25. Ness GC, Zhao Z, Lopez D. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation. Arch Biochem Biophys 1996; 325: 242-248.
26. Fuhrman B, Elis A, Aviram M. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesteol synthesis and augmentation of LDL receptoractivity in macrophages. Biochem Biophys Res Commun 1997; 233: 658-662.
27. Fuhrman B, Judith O, Keidar S, Ben-Yaish L, Kaplan M, Aviram M. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic Biol Med 1997; 23: 34-46.
28. Ramakrishma RR, Platel K, Srinivasan K. In vitro influence of spices and spice-active principles on digestive enzymes of rat pancreas and small intestine. Nahrung 2003; 47: 408-412.
29. Liu N, Huo G, Zhang L, Zhang X. Abstract [Effect of Zingiber OfficinaleRosc on lipid peroxidation in hyperlipidemia rats]. Wei Sheng Yan Jiu 2003; 32: 22-23. Chinese.
30. Hashimoto K, Satoh K, Murata P, Makino B, Sakakibara I, Kase Y, et al. Component of Zingiber officinale that improves the enhancement of small intestinal transport. Planta Med 2002; 65: 936-969.
31. Srinivasan K, Sambaiah K. The effect of spices on cholesterol 7 alpha-hydroxylase activity and on serum and hepatic cholesterol levels in the rat. Int J Vitam Nutr Res 1991; 61: 364-369.
32. Tanabe M, Chen YD, Saito K, Kano Y. Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chem Pharm Bull (Tokyo) 1993; 41: 710-713.
33. Verma SK, Singh M, Jain P, Bordia A. Protective effect of ginger, Zingiber officinale Rosc on experimental atherosclerosis in rabbits. Indian J Exp Biol 2004; 42: 736-738.